The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking ...

Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

Virginia Giuffre chronicled some of the most horrific details of her encounters with Epstein and Britain’s Prince Andrew in a ...

Prosecutors shared the possible motive as they asked a judge for permission to admit evidence around the circumstances of the ...

The advancements of minimally invasive cardiac surgery for seniors often give them a better chance for a speedy recovery, as ...

The 367-page-long book contains detailed accounts of Giuffre's encounters with Jeffrey Epstein, Ghislaine Maxwell and Prince ...

Virginia Giuffre's memoir goes into graphic detail about her alleged sexual abuse by Jeffrey Epstein, who she said trafficked ...

Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable ...

A large-scale analysis found that the number of abdominal aortic aneurysm patients has more than tripled over 13 years.

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...